Glenmark Pharmaceuticals Market Cap

Glenmark Pharmaceuticals has a market cap or net worth of 615.51 billion as of July 11, 2025. Its market cap has increased by 79.77% in one year.

Market Cap

615.51B

Enterprise Value

623.18B

Revenue

134.35B

Ranking

n/a

PE Ratio

58.78

Stock Price

2,181.55

Market Cap Chart

Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 615.51B, an increase of 53,454.90%. That is a compound annual growth rate of 29.77%.

Market Cap History

Date	Market Cap	% Change
Jul 11, 2025	615.51B	35.55%
Dec 31, 2024	454.07B	88.44%
Dec 29, 2023	240.96B	101.33%
Dec 30, 2022	119.68B	-19.75%
Dec 31, 2021	149.14B	7.10%
Dec 31, 2020	139.25B	42.03%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Reliance Industries	19.28T
HDFC Bank	15.38T
Tata Consultancy Services	12.24T
Bharti Airtel	11.78T
ICICI Bank	10.16T
State Bank of India	7,211.09B
Infosys	6,696.87B
Bajaj Finance	5,888.97B

Market Cap Rankings